Unknown

Dataset Information

Disproportionality analysis of quinolone safety in children using data from the FDA adverse event reporting system (FAERS).


ABSTRACT:

Background

Quinolones are widely prescribed for the treatment or prevention of infectious diseases in children. To gain further insight into quinolone-associated adverse event (AE) in children and better protect pediatric patients, continued surveillance of safety data is essential. The purpose of this study was to characterize the safety profiles of quinolone-associated AEs in children by mining the FDA adverse event reporting system (FAERS).

Methods

FAERS reports from quarter 1 of 2004 to quarter 1 of 2022 were included in the study. The Medical Dictionary for Regulatory Activities (MedDRA) was used to identify adverse events. Reporting odds ratios (ROR) corresponding 95% confidence intervals (CIs) and information component (IC) along with 95% CIs were calculated to detect

SUBMITTER: Kong W 

PROVIDER: S-EPMC9874243 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature